Marc N. Casper - Feb 27, 2024 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Chairman & CEO, Director
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Stock symbol
TMO
Transactions as of
Feb 27, 2024
Transactions value $
-$9,063,858
Form type
4
Date filed
2/29/2024, 04:56 PM
Previous filing
Feb 26, 2024
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $1.91M +10K +7.78% $190.59 138K Feb 27, 2024 Direct
transaction TMO Common Stock Sale -$168K -300 -0.22% $561.59 138K Feb 27, 2024 Direct F1, F2
transaction TMO Common Stock Sale -$563K -1K -0.72% $562.68 137K Feb 27, 2024 Direct F1, F3
transaction TMO Common Stock Sale -$968K -1.72K -1.25% $563.71 135K Feb 27, 2024 Direct F1, F4
transaction TMO Common Stock Sale -$1.98M -3.5K -2.58% $564.66 132K Feb 27, 2024 Direct F1, F5
transaction TMO Common Stock Sale -$1.07M -1.9K -1.44% $565.75 130K Feb 27, 2024 Direct F1, F6
transaction TMO Common Stock Sale -$898K -1.59K -1.22% $566.59 128K Feb 27, 2024 Direct F1, F7
transaction TMO Common Stock Options Exercise $1.91M +10K +7.78% $190.59 138K Feb 28, 2024 Direct
transaction TMO Common Stock Sale -$51.5K -91 -0.07% $565.55 138K Feb 28, 2024 Direct F1, F8
transaction TMO Common Stock Sale -$227K -400 -0.29% $567.00 138K Feb 28, 2024 Direct F1, F9
transaction TMO Common Stock Sale -$903K -1.59K -1.15% $568.20 136K Feb 28, 2024 Direct F1, F10
transaction TMO Common Stock Sale -$1.2M -2.1K -1.54% $569.43 134K Feb 28, 2024 Direct F1, F11
transaction TMO Common Stock Sale -$825K -1.45K -1.08% $570.44 133K Feb 28, 2024 Direct F1, F12
transaction TMO Common Stock Sale -$2.06M -3.6K -2.71% $571.40 129K Feb 28, 2024 Direct F1, F13
transaction TMO Common Stock Sale -$442K -773 -0.6% $572.26 128K Feb 28, 2024 Direct F1, F14
transaction TMO Common Stock Tax liability -$1.53M -2.67K -2.08% $572.03 126K Feb 28, 2024 Direct
holding TMO Common Stock 11.3K Feb 27, 2024 By Alison Casper 2020 Irrevocable Trust F15
holding TMO Common Stock 43.6K Feb 27, 2024 By Floral Park Associates, Inc.
holding TMO Common Stock 5K Feb 27, 2024 By MNC 2020 Irrevocable Trust F16

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10K -8.6% $0.00 106K Feb 27, 2024 Common Stock 10K $190.59 Direct
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10K -9.41% $0.00 96.3K Feb 28, 2024 Common Stock 10K $190.59 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $561.18 to $561.85, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13) and (14) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $562.20 to $563.15, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.22 to $564.19, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.26 to $565.25, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.29 to $566.28, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.36 to $567.24, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.03 to $565.875, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.38 to $567.22, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.74 to $568.61, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.94 to $569.93, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.98 to $570.93, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.985 to $571.97, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.00 to $572.835, inclusive.
F15 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F16 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.